Get started
Work

Supplementary Figure S6 from Axicabtagene Ciloleucel in Combination with the 4–1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11

Year: 2023
Type: supplementary-materials
Abstract: Correlation of Axi-cel CAR T-cell Peak With Utomilumab Dose and Peak Exposure
DOI: 10.1158/1078-0432.24304946
Authors: Michael D. Jain, David B. Miklos, Caron A. Jacobson, John M. Timmerman, Jennifer Sun, Jenny Nater, Xiang Fang, Ankit Patel, Madison Davis, Darren Heeke, Tan Trinh, Mike Mattie, Frank Neumann, Jenny J. Kim, Christina To, Simone Filosto, Ran Reshef
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4387609704
Cites:
Cited by:
Related to: 5